NYSEAMERICAN : VNRX
VolitionRx Limited — Key statistics
Healthcare · Medical Devices · United States
Last price 0.1953 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.00M |
| Enterprise Value | 11.62M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 14.20M |
| Shares Outstanding | 14.20M |
| Shares Change (YoY) | +44.16% |
| Shares Change (QoQ) | +33.01% |
| Owned by Insiders (%) | 2.85% |
| Owned by Institutions (%) | 16.66% |
| Float | 12.54M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.13 |
| Forward PS | 0.94 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.30 |
| Quick Ratio | 0.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.31 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -142.94% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 374.58% |
| Weighted Average Cost of Capital (WACC) | 22.50% |
| Revenue Per Employee | $43,124 |
| Profits Per Employee | -$457,897 |
| Employee Count | 57 |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -97.58% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 2.14 |
| Relative Strength Index (RSI) | 45.20 |
| Average Volume (20 Days) | 1,133,254 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.15M |
| Short Previous Month | 1.00M |
| Short % of Shares Out | 8.07% |
| Short % of Float | 9.13% |
| Short Ratio (days to cover) | 0.38 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.46M |
| Gross Profit | 2.46M |
| Operating Income | -19.45M |
| Pretax Income | -25.73M |
| Net Income | -26.10M |
| EBITDA | -18.57M |
| EBIT | -19.45M |
| Loss Per Share | -$3.80 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.79M |
| Total Debt | 11.41M |
| Net Cash | -8.62M |
| Net Cash Per Share | -$0.61 |
| Equity (Book Value) | -33.54M |
| Book Value Per Share | -2.67 |
| Working Capital | -9.40M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -19.56M |
| Capital Expenditures | -21,969 |
| Depreciation & Amortization | 874,461 |
| Net Borrowing | 1.10M |
| Free Cash Flow | -19.58M |
| FCF Per Share | -$1.38 |
Margins
| Measure | Value |
|---|
| Gross Margin | 100.00% |
| Operating Margin | -791.16% |
| Pretax Margin | -1,046.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -44.16% |
| Shareholder Yield | -44.16% |
| Earnings Yield | -1,798.78% |
| FCF Yield | -706.06% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.62 |
| Price Target Difference | 6,339.72% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 144.25% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 28, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -53.28 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |